voices from american medicine

Interest in health policies related to drug pricing has spiked in recent times. While remarkable research discoveries have positively escalated the pharmaceutical industry with release of more novel drugs, the question on how drugs should be priced is continually resurfacing. How are high drug costs justified when they become financially inaccessible to many patients, and what measures are being put in place to address these access gaps?

Host Frank Russomano welcomes Andrew Rosenberg J.D. of the CME Coalition and Thomas Sullivan, President of Rockpointe Corporation and editor of Policy and Medicine, to discuss recent developments in drug pricing.

Interest in health policies related to drug pricing has spiked in recent times. While remarkable research discoveries have positively escalated the pharmaceutical industry with release of more novel drugs, the question on how drugs should be priced is continually resurfacing. How are high drug costs justified when they become financially inaccessible to many patients, and what measures are being put in place to address these access gaps?

Host Frank Russomano welcomes Andrew Rosenberg J.D. of the CME Coalition and Thomas Sullivan, President of Rockpointe Corporation and editor of Policy and Medicine, to discuss recent developments in drug pricing.

Interest in health policies related to drug pricing has spiked in recent times. While remarkable research discoveries have positively escalated the pharmaceutical industry with release of more novel drugs, the question on how drugs should be priced is continually resurfacing. How are high drug costs justified when they become financially inaccessible to many patients, and what measures are being put in place to address these access gaps?

Host Frank Russomano welcomes Andrew Rosenberg J.D. of the CME Coalition and Thomas Sullivan, President of Rockpointe Corporation and editor of Policy and Medicine, to discuss recent developments in drug pricing.

There has been ongoing dialogue about the guidance needed to provide clarity on the reporting of indepedent medical education payments and the Sunshine Act. In this discussion, expert panelists analyze the definition of indirect payments and their exclusion as applied to CME-related payments and transfers of value. Additionally, they examine when payments to medical associations, physician speakers/lecturers, and related entities may or may not be reportable.

Host Frank Russomano welcomes Andrew Rosenberg J.D. of the CME Coalition and Thomas Sullivan, President of Rockpointe Corporation and editor of Policy and Medicine.

There has been ongoing dialogue about the guidance needed to provide clarity on the reporting of indepedent medical education payments and the Sunshine Act. In this discussion, expert panelists analyze the definition of indirect payments and their exclusion as applied to CME-related payments and transfers of value. Additionally, they examine when payments to medical associations, physician speakers/lecturers, and related entities may or may not be reportable.

Host Frank Russomano welcomes Andrew Rosenberg J.D. of the CME Coalition and Thomas Sullivan, President of Rockpointe Corporation and editor of Policy and Medicine.

Host Frank Russomano welcomes Rhondell Domilici, Regional Director for the Crohn's and Colitis Foundation, to discuss the organization's humble origins in 1967 as a small physician-patient collaborative, its rapid growth on a national scale, and the enduring mission that connects all past and present members.

Host Frank Russomano welcomes Rhondell Domilici, Regional Director for the Crohn's and Colitis Foundation, to discuss the organization's humble origins in 1967 as a small physician-patient collaborative, its rapid growth on a national scale, and the enduring mission that connects all past and present members.

Host Frank Russomano welcomes Rhondell Domilici, Regional Director for the Crohn's and Colitis Foundation, to discuss the organization's humble origins in 1967 as a small physician-patient collaborative, its rapid growth on a national scale, and the enduring mission that connects all past and present members.

Host Frank Russomano welcomes Dr. Tracey Haas, Chief Medical Officer of DocbookMD, an innovative communication platform for health care providers. Dr. Haas shares her story of how she and her husband, Dr. Tim Gueramy, discovered DocBookMD, the challenges of being a physician entreprenuer, and how she has integrated technology into everyday practice to improve patient care.

Host Frank Russomano welcomes Dr. Tracey Haas, Chief Medical Officer of DocbookMD, an innovative communication platform for health care providers. Dr. Haas shares her story of how she and her husband, Dr. Tim Gueramy, discovered DocBookMD, the challenges of being a physician entreprenuer, and how she has integrated technology into everyday practice to improve patient care.

There are far too many diseases that do not have proven means of prevention or effective treatments. As such, health care providers must gain better insights into the biology of these diseases to make a difference for the millions of patients who suffer from them. Precision medicine is an emerging approach for treatment and prevention that accounts for individual variability in genes, environment, and lifestyle. Host Frank Russomano welcomes Brian Wells, Associate Vice President of Health Technology and Academic Computing at Penn Medicine, to discuss how Penn Medicine contributes to the precision medicine initiative, from technological developments to supportive infrastructures.

There are far too many diseases that do not have proven means of prevention or effective treatments. As such, health care providers must gain better insights into the biology of these diseases to make a difference for the millions of patients who suffer from them. Precision medicine is an emerging approach for treatment and prevention that accounts for individual variability in genes, environment, and lifestyle. Host Frank Russomano welcomes Brian Wells, Associate Vice President of Health Technology and Academic Computing at Penn Medicine, to discuss how Penn Medicine contributes to the precision medicine initiative, from technological developments to supportive infrastructures.

There are far too many diseases that do not have proven means of prevention or effective treatments. As such, health care providers must gain better insights into the biology of these diseases to make a difference for the millions of patients who suffer from them. Precision medicine is an emerging approach for treatment and prevention that accounts for individual variability in genes, environment, and lifestyle. Host Frank Russomano welcomes Brian Wells, Associate Vice President of Health Technology and Academic Computing at Penn Medicine, to discuss how Penn Medicine contributes to the precision medicine initiative, from technological developments to supportive infrastructures.

There are far too many diseases that do not have proven means of prevention or effective treatments. As such, health care providers must gain better insights into the biology of these diseases to make a difference for the millions of patients who suffer from them. Precision medicine is an emerging approach for treatment and prevention that accounts for individual variability in genes, environment, and lifestyle. Host Frank Russomano welcomes Brian Wells, Associate Vice President of Health Technology and Academic Computing at Penn Medicine, to discuss how Penn Medicine contributes to the precision medicine initiative, from technological developments to supportive infrastructures.

The role of continuing medical education (CME) within government is an important and ever-changing area of high interest and scrutiny among many stakeholders. The CME Coalition is an advocacy group working directly with government officials, lobbyist and other healthcare interest groups to help define and refine what CME is, and the role supporters have in medical education.

Host Frank Russomano, reporting from the floor of the Alliance for Continuing Education in the Health Professions Annual Industry Summit in Philadelphia, speaks with Andrew Rosenberg and Thomas Sullivan. Mr. Rosenberg is Founding Partner of Thorn Run Partners and Senior Advisor for the CME Coalition. Thomas Sullivan is President of Rockpointe Corp., a science-based medical education company, and editor of Policy and Medicine, a website devoted to legal, regulatory, and compliance issues affecting the pharmaceutical and device industry.

The role of continuing medical education (CME) within government is an important and ever-changing area of high interest and scrutiny among many stakeholders. The CME Coalition is an advocacy group working directly with government officials, lobbyist and other healthcare interest groups to help define and refine what CME is, and the role supporters have in medical education.

Host Frank Russomano, reporting from the floor of the Alliance for Continuing Education in the Health Professions Annual Industry Summit in Philadelphia, speaks with Andrew Rosenberg and Thomas Sullivan. Mr. Rosenberg is Founding Partner of Thorn Run Partners and Senior Advisor for the CME Coalition. Thomas Sullivan is President of Rockpointe Corp., a science-based medical education company, and editor of Policy and Medicine, a website devoted to legal, regulatory, and compliance issues affecting the pharmaceutical and device industry.

The role of continuing medical education (CME) within government is an important and ever-changing area of high interest and scrutiny among many stakeholders. The CME Coalition is an advocacy group working directly with government officials, lobbyist and other healthcare interest groups to help define and refine what CME is, and the role supporters have in medical education.

Host Frank Russomano, reporting from the floor of the Alliance for Continuing Education in the Health Professions Annual Industry Summit in Philadelphia, speaks with Andrew Rosenberg and Thomas Sullivan. Mr. Rosenberg is Founding Partner of Thorn Run Partners and Senior Advisor for the CME Coalition. Thomas Sullivan is President of Rockpointe Corp., a science-based medical education company, and editor of Policy and Medicine, a website devoted to legal, regulatory, and compliance issues affecting the pharmaceutical and device industry.

Trauma care is one of the most complex health system infrastructures in the US. Depending on the type of injury sustained, a patient may require multidisciplinary intervention from any and/or every medical and surgical specialty, as well as all branches of allied health professionals, at a moment's notice. Given these requirements, the notion to physically move an entire trauma care center, from its staff and patient populations to its equipment, records, and maintenence operations, is a daunting challenge. At Penn Medicine, this monumental task was recently undertaken and completed successfully. Leading the effort was Garry L. Scheib, Chief Operating Officer of the University of Pennsylvania Health System, and Executive Director of the Hospital of the University of Pennsylvania. He joins host Frank Russomano to reflect on lessons learned from overseeing one of the biggest trauma care transition projects in American history.

Trauma care is one of the most complex health system infrastructures in the US. Depending on the type of injury sustained, a patient may require multidisciplinary intervention from any and/or every medical and surgical specialty, as well as all branches of allied health professionals, at a moment's notice. Given these requirements, the notion to physically move an entire trauma care center, from its staff and patient populations to its equipment, records, and maintenence operations, is a daunting challenge. At Penn Medicine, this monumental task was recently undertaken and completed successfully. Leading the effort was Garry L. Scheib, Chief Operating Officer of the University of Pennsylvania Health System, and Executive Director of the Hospital of the University of Pennsylvania. He joins host Frank Russomano to reflect on lessons learned from overseeing one of the biggest trauma care transition projects in American history.

Trauma care is one of the most complex health system infrastructures in the US. Depending on the type of injury sustained, a patient may require multidisciplinary intervention from any and/or every medical and surgical specialty, as well as all branches of allied health professionals, at a moment's notice. Given these requirements, the notion to physically move an entire trauma care center, from its staff and patient populations to its equipment, records, and maintenence operations, is a daunting challenge. At Penn Medicine, this monumental task was recently undertaken and completed successfully. Leading the effort was Garry L. Scheib, Chief Operating Officer of the University of Pennsylvania Health System, and Executive Director of the Hospital of the University of Pennsylvania. He joins host Frank Russomano to reflect on lessons learned from overseeing one of the biggest trauma care transition projects in American history.